Profil
Kelly Devine Deck is currently the Chief Financial Officer at Inhibrx, Inc. and a Trustee at The Fleet Science Center.
Previously, she worked as the Executive Director-Finance at Apricus Biosciences, Inc. from 2013 to 2018.
Aktive Positionen von Kelly Deck
| Unternehmen | Position | Beginn |
|---|---|---|
| INHIBRX, INC. | Director of Finance/CFO | - |
| Fleet Science Center | Director/Board Member | - |
Ehemalige bekannte Positionen von Kelly Deck
| Unternehmen | Position | Ende |
|---|---|---|
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01.01.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INHIBRX, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Health Technology |
| Fleet Science Center |
